Clinical Program Risk Radar

Oncology Phase 2 Small/Mid-Cap Sponsor Edition

Monitor registry stop signals, timeline staleness, recruitment burden, missing-results signals, and sponsor-level public risk patterns across oncology Phase 2 assets.

Built from ClinicalTrials.gov registry text and snapshot history. Signals reflect what is publicly observable — not clinical outcome predictions, compliance determinations, or assessments of sponsor financial health.

Open methodology Request custom monitoring

Updated June 2026

Assets tracked

4

Distinct asset programs in the current public screen.

Linked trials

5

ClinicalTrials.gov records linked into the current edition.

Registry stop assets

2

Assets with terminated, withdrawn, or suspended status signals.

Timeline watchlist

2

Assets with public date or update staleness patterns.

Results not found

1

Completed assets where public results were not found in the record.

Manual review

0

Assets still requiring contextual review.

Public risk-signal table

Score columns (Registry, Timeline, Burden, Results, Program risk) are 0–5 dots — more dots = stronger signal. Program risk is the composite score; click column headers to re-sort.

CPRR asset risk-signal table. Sortable by name, sponsor, indication, and all score columns.
			Primary label	Confidence
Lumicras	Mirati Therapeutics	NSCLC	Registry Stop Signal	Medium
Cellara	Cellara Therapeutics	ovarian cancer	Registry Stop Signal	Medium
CLDNova	Claudia Bio	gastric cancer	Timeline Staleness Signal	Medium
Radionex	Radiant Nuclear	prostate cancer	Results Not Found Signal	Medium

Recently stopped programs

Registry stop signals

Cellara: Cellara is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Lumicras: Lumicras is flagged as registry stop signal because public records show a registry stop signal, timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Long-running or stale programs

Timeline watchlist

CLDNova: CLDNova is flagged as timeline staleness signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Lumicras: Lumicras is flagged as registry stop signal because public records show a registry stop signal, timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Completed with no public results found

Results availability

Radionex: Radionex is flagged as results not found signal because public records show public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Sponsor patterns

Sponsor public-signal view

Cellara Therapeutics: 1 watchlist assets
Claudia Bio: 1 watchlist assets
Mirati Therapeutics: 1 watchlist assets
Radiant Nuclear: 1 watchlist assets

Risk monitoring

Receive Clinical Program Updates by Email

Use this form to monitor specific assets or sponsors monthly, compare small-cap oncology programs, and choose which CSV files you want delivered by email.